Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 98 | NANETS2023 | Next issue

NANETS 2023

Abstracts

Clinical – Surgery/Applied Pathology

Previous section
Clinical – Nuclear Medicine/Interventional Radiology/Imaging
Table of contents
Next section
Population Science

ea0098c43 | Clinical – Surgery/Applied Pathology

Accuracy of DOTATATE PET imaging in the preoperative planning of small bowel neuroendocrine tumor resection

ea0098c44 | Clinical – Surgery/Applied Pathology

Real-time prospective DAXX/ATRX testing of 186 consecutive surgically resected pancreatic neuroendocrine tumors reveals loss of expression correlates with distant metastasis

ea0098c45 | Clinical – Surgery/Applied Pathology

Grade progression in gastrointestinal neuroendocrine tumors

ea0098c46 | Clinical – Surgery/Applied Pathology

Peptide receptor radionuclide therapy improves survival in patients who progress after resection of gastroenteropancreatic neuroendocrine tumors

ea0098c47 | Clinical – Surgery/Applied Pathology

Surgical cytoreduction vs systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETS): NCDB analysis

ea0098c48 | Clinical – Surgery/Applied Pathology

Predictors of low-to-high grade progression in pancreatic neuroendocrine tumors

ea0098c49 | Clinical – Surgery/Applied Pathology

Post-procedure outcomes of liver-directed therapy of neuroendocrine liver metastases

ea0098c50 | Clinical – Surgery/Applied Pathology

Phenotype Genotype Correlation in Multiple Endocrine Neoplasia Type 1

ea0098c51 | Clinical – Surgery/Applied Pathology

A prospective phase ii single-arm trial on neoadjuvant peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE followed by surgery for pancreatic neuroendocrine tumors (NeoLuPaNET)

ea0098c52 | Clinical – Surgery/Applied Pathology

Translational potential of a receptor-targeted contrast agent for fluorescence-guided applications in pancreatic neuroendocrine tumors

ea0098c53 | Clinical – Surgery/Applied Pathology

Abstract unavailable

ea0098c54 | Clinical – Surgery/Applied Pathology

Tissue section thickness of Ki67 immunohistochemistry does not have a correlative effect on pancreatic neuroendocrine tumor grading

ea0098c55 | Clinical – Surgery/Applied Pathology

Association of long-term PPI use with low-risk gastric neuroendocrine tumor

ea0098c56 | Clinical – Surgery/Applied Pathology

Comparative gene expression and pathway analysis of neuroendocrine neoplasms in relation to clinical outcomes and tumor location

ea0098c57 | Clinical – Surgery/Applied Pathology

Perioperative management of carcinoid crisis: protocol for a modified Delphi international expert consensus statement with patient engagement

ea0098c58 | Clinical – Surgery/Applied Pathology

Do Pancreatic Well-differentiated Neuroendocrine Tumor (NET) Progress to Poorly-differentiated Neuroendocrine Carcinoma (NEC)?

ea0098c59 | Clinical – Surgery/Applied Pathology

High grade medullary thyroid carcinoma predicts greater lymph node burden in the ipsilateral lateral neck

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more